Logo image of UXIN

UXIN LTD - ADR (UXIN) Stock Fundamental Analysis

USA - NASDAQ:UXIN - US91818X3061 - ADR

2.66 USD
-0.26 (-8.9%)
Last: 10/28/2025, 4:30:02 PM
Fundamental Rating

1

Overall UXIN gets a fundamental rating of 1 out of 10. We evaluated UXIN against 121 industry peers in the Specialty Retail industry. UXIN may be in some trouble as it scores bad on both profitability and health. UXIN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year UXIN has reported negative net income.
UXIN had negative earnings in each of the past 5 years.
In the past 5 years UXIN always reported negative operating cash flow.
UXIN Yearly Net Income VS EBIT VS OCF VS FCFUXIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of -15.27%, UXIN is doing worse than 80.99% of the companies in the same industry.
Industry RankSector Rank
ROA -15.27%
ROE N/A
ROIC N/A
ROA(3y)-84.07%
ROA(5y)-72.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UXIN Yearly ROA, ROE, ROICUXIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

UXIN has a worse Gross Margin (7.02%) than 94.21% of its industry peers.
UXIN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for UXIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-36.4%
UXIN Yearly Profit, Operating, Gross MarginsUXIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

0

2. Health

2.1 Basic Checks

UXIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
UXIN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
UXIN Yearly Shares OutstandingUXIN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
UXIN Yearly Total Debt VS Total AssetsUXIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of -12.45, we must say that UXIN is in the distress zone and has some risk of bankruptcy.
UXIN has a Altman-Z score of -12.45. This is amonst the worse of the industry: UXIN underperforms 92.56% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.45
ROIC/WACCN/A
WACC4.77%
UXIN Yearly LT Debt VS Equity VS FCFUXIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B -2B

2.3 Liquidity

A Current Ratio of 0.44 indicates that UXIN may have some problems paying its short term obligations.
The Current ratio of UXIN (0.44) is worse than 94.21% of its industry peers.
A Quick Ratio of 0.17 indicates that UXIN may have some problems paying its short term obligations.
With a Quick ratio value of 0.17, UXIN is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.17
UXIN Yearly Current Assets VS Current LiabilitesUXIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

6

3. Growth

3.1 Past

UXIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
The Revenue has grown by 34.91% in the past year. This is a very strong growth!
The Revenue has been decreasing by -2.84% on average over the past years.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)34.91%
Revenue growth 3Y27.89%
Revenue growth 5Y-2.84%
Sales Q2Q%42.47%

3.2 Future

Based on estimates for the next years, UXIN will show a very strong growth in Earnings Per Share. The EPS will grow by 33.99% on average per year.
UXIN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 122.89% yearly.
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3Y33.99%
EPS Next 5YN/A
Revenue Next Year17.05%
Revenue Next 2YN/A
Revenue Next 3Y122.89%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UXIN Yearly Revenue VS EstimatesUXIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 5B 10B 15B
UXIN Yearly EPS VS EstimatesUXIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2027 0 -20 -40 -60 -80 -100

1

4. Valuation

4.1 Price/Earnings Ratio

UXIN is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UXIN Price Earnings VS Forward Price EarningsUXIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UXIN Per share dataUXIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as UXIN's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3Y33.99%

0

5. Dividend

5.1 Amount

No dividends for UXIN!.
Industry RankSector Rank
Dividend Yield N/A

UXIN LTD - ADR

NASDAQ:UXIN (10/28/2025, 4:30:02 PM)

2.66

-0.26 (-8.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)09-22 2025-09-22
Earnings (Next)11-24 2025-11-24
Inst Owners0.15%
Inst Owner Change0%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap548.41M
Revenue(TTM)2.19B
Net Income(TTM)-298000000
Analysts43.33
Price TargetN/A
Short Float %4.99%
Short Ratio1.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.5
BVpS-0.25
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.27%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.02%
FCFM N/A
ROA(3y)-84.07%
ROA(5y)-72.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-36.4%
F-ScoreN/A
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.17
Altman-Z -12.45
F-ScoreN/A
WACC4.77%
ROIC/WACCN/A
Cap/Depr(3y)92.95%
Cap/Depr(5y)65.68%
Cap/Sales(3y)1.23%
Cap/Sales(5y)1.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y33.33%
EPS Next 2YN/A
EPS Next 3Y33.99%
EPS Next 5YN/A
Revenue 1Y (TTM)34.91%
Revenue growth 3Y27.89%
Revenue growth 5Y-2.84%
Sales Q2Q%42.47%
Revenue Next Year17.05%
Revenue Next 2YN/A
Revenue Next 3Y122.89%
Revenue Next 5YN/A
EBIT growth 1Y22.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year43.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.32%
OCF growth 3YN/A
OCF growth 5YN/A

UXIN LTD - ADR / UXIN FAQ

What is the fundamental rating for UXIN stock?

ChartMill assigns a fundamental rating of 1 / 10 to UXIN.


What is the valuation status for UXIN stock?

ChartMill assigns a valuation rating of 1 / 10 to UXIN LTD - ADR (UXIN). This can be considered as Overvalued.


Can you provide the profitability details for UXIN LTD - ADR?

UXIN LTD - ADR (UXIN) has a profitability rating of 0 / 10.


Can you provide the financial health for UXIN stock?

The financial health rating of UXIN LTD - ADR (UXIN) is 0 / 10.